The novel activity of carbamazepine as an activation modulator extends from NaV 1.7 mutations to the NaV 1.8-S242T mutant channel from a patient with painful diabetic neuropathy

dc.citation.doi10.1124/MOL.118.113076
dc.citation.epage1269
dc.citation.spage1256
dc.contributor.authorC Han
dc.contributor.authorAndreas Themistocleous
dc.contributor.authorM Estacion
dc.contributor.authorF Dib-Hajj
dc.contributor.authorI Blesneac
dc.contributor.authorE et al
dc.date.accessioned2023-04-13T11:08:27Z
dc.date.available2023-04-13T11:08:27Z
dc.identifier.citationISI
dc.identifier.issn0026-895X
dc.identifier.urihttps://hdl.handle.net/10539/35084
dc.journal.titleMOLECULAR PHARMACOLOGY
dc.journal.volume94
dc.titleThe novel activity of carbamazepine as an activation modulator extends from NaV 1.7 mutations to the NaV 1.8-S242T mutant channel from a patient with painful diabetic neuropathy
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Journal.pdf
Size:
1.78 MB
Format:
Adobe Portable Document Format
Description:
Journal